Lessons Learned from Clinical Trials in Acute Heart Failure: Phase 3 Drug Trials

被引：3

作者：

O'Connor, Christopher M. ^{[1
]}

Fiuzat, Mona ^{[1
]}

机构：

[1] Duke Univ, Med Ctr, Div Cardiol, Durham, NC 27710 USA

来源：

HEART FAILURE CLINICS | 2011年 / 7卷 / 04期

关键词：

Acute heart failure; Phase 3 clinical trials; Endpoints; Efficacy; Safety; RANDOMIZED CONTROLLED-TRIAL; ANTAGONIST; ROLOFYLLINE; NESIRITIDE;

D O I：

10.1016/j.hfc.2011.06.013

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Phase 3 clinical trials in acute heart failure are conducted to allow safety and efficacy data to be collected for the evaluation of treatment strategies, including drugs, devices, diagnostics, or nonpharmacological interventions. There are several important features regarding the conduct of phase 3 clinical trials in acute heart failure. This article describes in detail these important aspects of conducting phase 3 clinical trials in an acute heart failure population.

引用

页码：451 / +

页数：7

共 50 条

[1] Clinical Trials of Pharmacological Therapies in Acute Heart Failure Syndromes Lessons Learned and Directions Forward
Felker, G. Michael
Pang, Peter S.
Adams, Kirkwood F.
Cleland, John G. F.
Cotter, Gad
Dickstein, Kenneth
Filippatos, Gerasimos S.
Fonarow, Gregg C.
Greenberg, Barry H.
Hernandez, Adrian F.
Khan, Sadiya
Komajda, Michel
Konstam, Marvin A.
Liu, Peter P.
Maggioni, Aldo P.
Massie, Barry M.
McMurray, John J.
Mehra, Mandeep
Metra, Marco
O'Connell, John
O'Connor, Christopher M.
Pina, Ileana L.
Ponikowski, Piotr
Sabbah, Hani N.
Teerlink, John R.
Udelson, James E.
Yancy, Clyde W.
Zannad, Faiez
Gheorghiade, Mihai
CIRCULATION-HEART FAILURE, 2010, 3 (02) : 314 - 325
[2] Reassessing Phase II Heart Failure Clinical Trials Consensus Recommendations
Butler, Javed
Hamo, Carine E.
Udelson, James E.
O'Connor, Christopher
Sabbah, Hani N.
Metra, Marco
Shah, Sanjiv J.
Kitzman, Dalane W.
Teerlink, John R.
Bernstein, Harold S.
Brooks, Gabriel
Depre, Christophe
DeSouza, Mary M.
Dinh, Wilfried
Donovan, Mark
Frische-Danielson, Regina
Frost, Robert J.
Garza, Dahlia
Gohring, Udo-Michael
Hellawell, Jennifer
Hsia, Judith
Ishihara, Shiro
Kay-Mugford, Patricia
Koglin, Joerg
Kozinn, Marc
Larson, Christopher J.
Mayo, Martha
Gan, Li-Ming
Mugnier, Pierrre
Mushonga, Sekayi
Roessig, Lothar
Russo, Cesare
Salsali, Afshin
Satler, Carol
Shi, Victor
Ticho, Barry
van der Laan, Michael
Yancy, Clyde
Stockbridge, Norman
Gheorghiade, Mihai
CIRCULATION-HEART FAILURE, 2017, 10 (04)
[3] Pediatric Cardiovascular Drug Trials, Lessons Learned
Li, Jennifer S.
Cohen-Wolkowiez, Michael
Pasquali, Sara K.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2011, 58 (01) : 4 - 8
[4] Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials
Gupta, Subash C.
Patchva, Sridevi
Aggarwal, Bharat B.
AAPS JOURNAL, 2013, 15 (01): : 195 - 218
[5] A Review of Phase II Acute Heart Failure Syndromes Clinical Trials
Pang, Peter S.
Gheorghiade, Mihai
HEART FAILURE CLINICS, 2011, 7 (04) : 441 - +
[6] End Points for Clinical Trials in Acute Heart Failure Syndromes
Allen, Larry A.
Hernandez, Adrian F.
O'Connor, Christopher M.
Felker, G. Michael
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (24) : 2248 - 2258
[7] From the Laboratory to Clinical Trials and Back Again: Lessons Learned from HIV Prevention Trials
Sibeko, Sengeziwe
Makvandi-Nejad, Shokouh
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2013, 69 : 106 - 115
[8] Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials
Subash C. Gupta
Sridevi Patchva
Bharat B. Aggarwal
The AAPS Journal, 2013, 15 : 195 - 218
[9] Clinical Trials for AKI: Lessons Learned From the ARDS Network
Liu, Kathleen D.
SEMINARS IN NEPHROLOGY, 2020, 40 (02) : 243 - 246
[10] LESSONS LEARNED FROM THE DENUFOSOL TRIALS
Moss, Richard B.
PEDIATRIC PULMONOLOGY, 2011, : 177 - 178

← 1 2 3 4 5 →